Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01086956
Other study ID # 4-2008-0319
Secondary ID
Status Completed
Phase N/A
First received March 12, 2010
Last updated November 10, 2010
Start date September 2008
Est. completion date December 2009

Study information

Verified date November 2010
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority Korea: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare metabolic and stress responses in combined general/epidural anesthesia in geriatric cancer patients.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 2009
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group 65 Years and older
Eligibility Inclusion Criteria:

- elective RRP for prostatic cancer scheduled in the morning (9-11 a.m.)

- patients aged more than 65 years

- ASA physical status I or II

- absence of contraindications to epidural approach

- absence of a history of chronic pain or opioid medication

Exclusion Criteria:

- contraindication to epidural catheterization

Study Design

Allocation: Randomized, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Drug:
epidural infusion of saline, ropivecaine, or ropivacaine and sufentanil


Locations

Country Name City State
Korea, Republic of Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary plasma glucose, insulin, cortisol, epinephrine, norepinephrine, prolactin from preoperative baseline to postoperative 24 hours No
See also
  Status Clinical Trial Phase
Withdrawn NCT05191017 - Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC Phase 1/Phase 2
Completed NCT00970203 - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer Phase 2
Completed NCT00643617 - CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry N/A
Recruiting NCT05252390 - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Phase 1/Phase 2
Completed NCT02687308 - Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique N/A
Completed NCT01284608 - Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT) N/A
Completed NCT04421781 - Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary Results
Recruiting NCT05740956 - A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors Phase 1
Enrolling by invitation NCT03173924 - 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer Phase 2
Not yet recruiting NCT05851521 - To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES) N/A
Completed NCT01998685 - Prothrombotic Factors and Anaesthesia in Prostate Cancer N/A
Completed NCT01477749 - Sipuleucel-T Manufacturing Demonstration Study Phase 2
Not yet recruiting NCT06439784 - Contribution of the VERITON-CT Camera in Prostate Bone Radiostereotaxy N/A
Terminated NCT03606889 - Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-prostatectomy Analgesia N/A
Completed NCT03481816 - Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines Phase 1
Completed NCT01171729 - Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer Phase 1/Phase 2
Recruiting NCT05623878 - 68Ga-labeled NY108 PET Imaging in Patients Early Phase 1
Not yet recruiting NCT05184790 - LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Completed NCT02564120 - North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
Active, not recruiting NCT01787630 - To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During Radiotherapy Phase 2/Phase 3